B-230 Rt-pcr detection and monitoring of infection in periodontal disease: a model of herpesviral-bacterial synergism

D J Vigerust
DOI: https://doi.org/10.1093/clinchem/hvae106.589
IF: 12.114
2024-10-01
Clinical Chemistry
Abstract:Abstract Background Periodontal disease results in the breakdown of tissue and ultimately bone and tooth loss. The prevalence of periodontal disease in most countries exceeds 50% and is a direct contributor to a variety of systemic chronic diseases. In addition to bacterial pathogens there is evidence of fungal and viral pathogens having a role in the genesis of inflammation and release of cytokines that stimulate bone and tooth loss. Herpes viruses such as Epstein-Barr virus (EBV), Cytomegalovirus (CMV) and Herpes Simplex 1and 2 (HSV-1 and 2), are seen in less than 5% of normal periodontal tissues but in excess of 50% in severe periodontitis. Epithelial infection with Herpesviruses can lead to impaired and inappropriate immune responses that drive immune evasion and tissue destruction. Viral infection can also alter the expression of proteins in the infected tissues that result in enhanced adherence of bacterial species like Porphyromonas gingivalis and promote active systemic disease. This viral-bacterial synergism is a mechanism of severe disease and should be proactively monitored in dental and medical patients to reduce the burden of morbidity and mortality. Methods Several of the eight Herpesviruses have been shown to contribute to cardiovascular disease (CVD), Alzheimer’s, GI cancers and liver disease. Our laboratory has developed and implemented as an LDT, an RT-PCR assay that detects the presence of the Keystone bacterial pathogens (Porphyrmonas gingivalis [Pg], Fusobacterium nucleatum [Fn],Treponema denticola [Td], Tannerella forsythia [Tf] and Aggregatibacter actinomycetemcomitans [Aa]), Candida spp., Streptococcus spp. related to caries formation and four Herpesviruses (EBV, CMV, HSV 1 and 2). Results The major pathogenic determinants of severe periodontitis are active herpesviruses, presence of keystone bacterial species, and chronic production of proinflammatory cytokines (TNF-α, IL-1, IL-6). Data from more than 500 patients demonstrates the frequent presence of EBV and CMV in patients also infected with Pg, Td and Fn suggesting a synergism that promotes aggressive periodontitis. Conclusions The literature and our data argue for a proactive periodontal testing program that includes viral and bacterial targets to best address and mitigate periodontal disease and the reduce risks for chronic systemic diseases such as CVD, metabolic disease and neurodegenerative disease.
medical laboratory technology
What problem does this paper attempt to address?